Literature DB >> 6426164

Kaposi's sarcoma and malignant lymphoma in AIDS.

H J Leu, J Schneider, T Hardmeier, R Maurer, R Lüthy, R Burger, H R Burger, M Krause.   

Abstract

A 48-year-old homosexual with contacts in different countries, including Haiti, presented with multiple pigmented or bluish nodules on both lower legs and upper arms. He had a history of secondary syphilis, hepatitis B and herpes zoster ophthalmicus. Biopsies of the skin tumors revealed a typical Kaposi's sarcoma of low grade malignancy. The endothelial origin of the tumor was indicated by the presence of specific endothelial organelles (Weibel-Palade bodies) in the cytoplasma of the tumor cells. Erythrocyte phagocytosis was found in tumor cells within and without the vascular channels. Laboratory tests were compatible with the clinical diagnosis of an acquired immune deficiency syndrome (AIDS) with a helper: suppressor T-lymphocyte ratio of 0.28 and a cutaneous anergy. In the course of the illness tumors of the stomach and duodenum were detected. Histology showed a malignant non-Hodgkin lymphoma of high grade malignancy. Within weeks the patient died in a cachectic state. Autopsy revealed a Kaposi's sarcoma of the skin with metastases in the stomach and a wide-spread malignant lymphoma in the gastrointestinal tract, in several visceral organs and in many lymph nodes.

Entities:  

Mesh:

Year:  1984        PMID: 6426164     DOI: 10.1007/bf00695236

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  29 in total

1.  Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes.

Authors:  A G OETTLE
Journal:  Acta Unio Int Contra Cancrum       Date:  1962

2.  Kaposi's sarcoma in homosexual men-a report of eight cases.

Authors:  K B Hymes; T Cheung; J B Greene; N S Prose; A Marcus; H Ballard; D C William; L J Laubenstein
Journal:  Lancet       Date:  1981-09-19       Impact factor: 79.321

Review 3.  Kaposi's sarcoma in lymph nodes concurrent with Hodgkin's disease.

Authors:  A Carbone; R Volpe
Journal:  Am J Clin Pathol       Date:  1983-08       Impact factor: 2.493

4.  Kaposi's sarcoma and immunosuppressive therapy: an appraisal.

Authors:  R W Gange; E W Jones
Journal:  Clin Exp Dermatol       Date:  1978-06       Impact factor: 3.470

5.  Factor VIII in Kaposi's sarcoma.

Authors:  L G Guarda; E G Silva; N G Ordóñez; J L Smith
Journal:  Am J Clin Pathol       Date:  1981-08       Impact factor: 2.493

6.  AIDS--two years later.

Authors:  J W Curran
Journal:  N Engl J Med       Date:  1983-09-08       Impact factor: 91.245

7.  Tumor conference #41: spontaneously disappearing Kaposi's sarcoma.

Authors:  R S Bart; A W Kopf
Journal:  J Dermatol Surg Oncol       Date:  1982-04

8.  Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implications.

Authors:  B Safai; V Miké; G Giraldo; E Beth; R A Good
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

9.  Association of Kaposi's sarcoma and prior immunosuppressive therapy: a 5-year material of Kaposi's sarcoma in Norway.

Authors:  O Klepp; O Dahl; J T Stenwig
Journal:  Cancer       Date:  1978-12       Impact factor: 6.860

10.  Primary Kaposi's sarcoma in lymph nodes concurrent with chronic lymphatic leukemia.

Authors:  Z Weshler; A Leviatan; D Krasnokuki; J Kopolovitch
Journal:  Am J Clin Pathol       Date:  1979-02       Impact factor: 2.493

View more
  2 in total

1.  Weibel-Palade bodies in Kaposi's sarcoma cells.

Authors:  K H Marquart
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

2.  Recognition of heterogeneous lymphokine-activated killer (LAK) receptors on Kaposi's sarcoma cells, endothelial cells, and monocytes/macrophages: evidence of distinct LAK-cell antigen on Kaposi's sarcoma cells--potential for use of LAK cells for immunotherapy.

Authors:  M U Rahman; A Mazumder
Journal:  J Clin Immunol       Date:  1992-07       Impact factor: 8.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.